Cleveland Clinic study links gut microbiome and aggressive prostate cancer
Researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. While more research will be necessary, the study’s lead author says...
Intestinal microbiota drive CRPC
Data published in Science provide evidence that the intestinal microbiota can drive prostate cancer towards castration resistance by providing an alternative source of androgens. Original article: Pernigoni, N. et al. Commensal bacteria promote endocrine resistance in...
Hormone-producing bacteria drive prostate cancer
During androgen-deprivation therapy, certain bacteria in the gut can synthesize androgens, thereby promoting tumor progression and therapy resistance. Androgen-deprivation therapy (ADT) removes the hormones that fuel prostate tumor growth and is the standard treatment...
